Clinical Reproductive Immunology

Dr. Racicot has over fifteen years of experience working with cell-based assays, in vivo disease models (rodents), and population-based outcome studies related to women’s health, immunology, and neurodevelopment. She has significant experience developing cross-functional collaborations with scientific and clinical leaders in the fields of women’s health and pediatrics demonstrated by previous and ongoing work as a co-investigator on the nation-wide ECHO program funded by the National Institute of Health. She was the treasurer and chair of the 2019 meeting of the American Society of Reproductive Immunology.

I. Introduction

II. Diagnostic utility of Immune Cells in recurrent implantation failure and early pregnancy loss
1. Decidual immune cells and diagnosis of pregnancy failure
2. Peripheral NK cells and diagnosis of pregnancy failure
3. NK cell KIR and placental HLA haplotype compatibility and pregnancy failure
4. T cell populations and cytokines in diagnosis of pregnancy failure
5. Diagnosis of auto-antibody syndromes in recurrent pregnancy loss (ANA/APA/TPO)

III. Diagnosis of pathogen-associated pregnancy complications and neonatal outcomes
6. Maternal auto-antibodies and fetal neurodevelopment
7. Diagnosis of reproductive tract infections during pregnancy (Bacterial; 1)
8. Diagnosis of reproductive tract infections during pregnancy (Viral; 2)
9. Postnatal screening and diagnosis of congenital infections
10. Endometrial microflora and diagnosis of pregnancy outcomes

IV. Appendix with summary and combination of diagnostic algorithms